• rarecandy
  • Posts
  • đź’° OpenAI’s o3: The AI Revolution Nobody Can Afford?

💰 OpenAI’s o3: The AI Revolution Nobody Can Afford?

PLUS: 🏥 AI Failures in Hospitals: Lives Are on the Line

In today’s newsletter:

  • News - đź’° OpenAI’s o3: The AI Revolution Nobody Can Afford?

  • Culture - đźŹĄ AI Failures in Hospitals: Lives Are on the Line

💰 OpenAI’s o3: The AI Revolution Nobody Can Afford?

Source: OpenAI

OpenAI’s o3 model is shaking up the AI world, proving there’s still room to push boundaries in performance. Using “test-time scaling,” which ramps up compute power during inference, o3 scored an impressive 88% on the ARC-AGI benchmark—far ahead of its predecessors and competitors. But this leap in capability comes at a hefty cost, with high-compute versions of o3 using over $1,000 per task, raising big questions about affordability and practicality. While it’s a breakthrough for complex problem-solving, it’s far from ready to replace your everyday AI assistant.

Despite the hype, o3 has its quirks, like struggling with simple tasks and the same pesky hallucination issues as other large language models. Test-time scaling might be the tech industry’s next big move to boost AI, but it also highlights the steep trade-offs between performance and cost. With whispers of pricey subscription tiers and next-gen inference chips in the works, it seems o3 and its successors might be reserved for deep-pocketed institutions tackling high-stakes problems—for now. If nothing else, o3 proves that the AI scaling story isn’t over yet—it’s just getting more complicated.

🗞️ In Other News…

🏥 AI Failures in Hospitals: Lives Are on the Line

Artificial intelligence is making waves in healthcare, from predicting patient outcomes to summarizing doctor visits, but keeping these tools reliable is proving a challenge. A study at Penn Medicine showed how algorithms can falter without regular checkups — during the pandemic, one model’s accuracy in predicting patient deaths dropped by 7%. Experts like oncologist Ravi Parikh warn that such lapses can have real-life consequences, such as missed conversations about treatment options. With no clear standards to evaluate and monitor these tools, hospitals often face a daunting task of ensuring their algorithms perform consistently, especially as data and environments change.

The problem isn’t just about tech glitches; it’s also about resources. Testing AI systems can take months of effort and specialized expertise, which many hospitals simply can’t afford. Some suggest AI could even monitor itself, though that raises costs and staffing needs further. Meanwhile, tools like documentation assistants are seeing big investments, but with error rates as high as 35%, they highlight the stakes of getting AI right in medicine. Until standards and smarter monitoring systems catch up, the healthcare industry faces a tricky balancing act: harnessing AI’s potential while avoiding its pitfalls.

VC Fundraising Rounds

  • Perplexity AI Inc., an AI startup developing a search product to rival Google, has raised $500 million in funding, tripling its valuation to $9 billion. (12/18/24)

  • SandboxAQ has raised over $300 million at a valuation exceeding $5.6 billion to advance its AI and quantum sensing technologies, focusing on specialized AI model development. (12/18/24)

  • Nuitee, a technology solution provider founded in 2017, has raised $48 million in a Series A funding round to expand its travel and hotel connectivity technology solutions. (12/18/24)

  • Databricks is securing an enormous $10 billion in additional funding, a move that will catapult its valuation to $62 billion. (12/17/24)

  • Basis, a startup focused on creating AI software for accounting firms, has secured $34 million in early-stage funding. (12/17/24)

Meme of the Day